These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6720175)

  • 1. [Phenylketonuria and hyperphenylalaninemia: clinico-genetic classification of 14 forms].
    Annenkov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):351-6. PubMed ID: 6720175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood.
    Güttler F
    Acta Paediatr Scand Suppl; 1980; 280():1-80. PubMed ID: 7006308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Classification and heterogeneity of hyperphenylalaninemias linked to a phenylalanine hydroxylase deficiency].
    Rey F; Munnich A; Lyonnet S; Rey J
    Arch Fr Pediatr; 1987; 44 Suppl 1():639-42. PubMed ID: 3329492
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenylalaninaemia or classical phenylketonuria (PKU)?
    Bickel H
    Neuropadiatrie; 1970 Apr; 1(4):379-82. PubMed ID: 5538079
    [No Abstract]   [Full Text] [Related]  

  • 5. The hyperphenylalaninemias in Israel.
    Cohen BE; Szeinberg A; Pollak S; Peled I; Likverman S; Crispin M
    Isr J Med Sci; 1973; 9(9):1393-5. PubMed ID: 4775121
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal hyperphenylalaninemia: a differential diagnosis.
    Menkes JH; Holtzman NA
    Neuropadiatrie; 1970 Apr; 1(4):434-46. PubMed ID: 5538081
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of N-ethyl-N-nitrosourea to produce mouse models for human phenylketonuria and hyperphenylalaninemia.
    McDonald JD; Bode VC; Dove WF; Shedlovsky A
    Prog Clin Biol Res; 1990; 340C():407-13. PubMed ID: 2381939
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe.
    Guldberg P; Romano V; Ceratto N; Bosco P; Ciuna M; Indelicato A; Mollica F; Meli C; Giovannini M; Riva E
    Hum Mol Genet; 1993 Oct; 2(10):1703-7. PubMed ID: 8268925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The problem in the differential diagnosis of various forms of hyperphenylalaninemia and in its diet therapy].
    Zammarchi E
    Minerva Pediatr; 1977 Apr; 29(12):873-7. PubMed ID: 559914
    [No Abstract]   [Full Text] [Related]  

  • 10. Mental retardation in a family with phenylketonuria and mild hyperphenylalaninemia.
    Cohen BE; Szeinberg A; Berman W; Aviad Y; Crispin M; Hirshorn N; Goland R
    Pediatrics; 1969 Nov; 44(5):655-60. PubMed ID: 5374976
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phenylalanine metabolites in the urine after oral phenylalanine loading. Significance for the discrimination between classical phenylketonuria and variations of hyperphenylalaninemia (heterozygotes and homozygotes)].
    Koepp P
    Fortschr Med; 1977 Mar; 95(10):627-31. PubMed ID: 844759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant forms of phenylketonuria].
    Bliumina MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(10):1462-5. PubMed ID: 6506948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular pathology and DNA diagnosis of phenylketonuria and hypermethioninemia].
    Nagao M
    Tanpakushitsu Kakusan Koso; 1998 May; 43(6):762-9. PubMed ID: 9612070
    [No Abstract]   [Full Text] [Related]  

  • 14. Discrimination of phenylketonurics from persistent hyperphenylalaninemia patients using a simple phenylalanine loading test.
    Blitzer MG; Bailey-Wilson JE; Shapira E
    Clin Chim Acta; 1985 Dec; 153(2):137-42. PubMed ID: 4064343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-chemical symptom: hyperphenylalaninemia].
    Nothjunge J
    Hippokrates; 1974 May; 45(2):203-9. PubMed ID: 4602712
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia.
    Thöny B; Ding Z; Martínez A
    FEBS Lett; 2004 Nov; 577(3):507-11. PubMed ID: 15556637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population.
    Eisensmith RC; Martinez DR; Kuzmin AI; Goltsov AA; Brown A; Singh R; Elsas LJ II; Woo SL
    Pediatrics; 1996 Apr; 97(4):512-6. PubMed ID: 8632937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical form of phenylketonuria caused by lack of dihydrobiopterin synthetase activity].
    Słowik M; Mańkowski T
    Pol Tyg Lek; 1992 Mar 2-9; 47(9-10):236-7. PubMed ID: 1437828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical problems of the genetic heterogeneity in hyperphenylalaninemias].
    Grüttner R; Sternowsky HJ; Rybak C
    Monatsschr Kinderheilkd (1902); 1971 Nov; 119(11):600-4. PubMed ID: 5133646
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of current practices in management of inherited disorders of amino acid metabolism in Western Europe.
    Wachtel U
    Hum Nutr Appl Nutr; 1986; 40 Suppl 1():61-9. PubMed ID: 3528074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.